Noted Authority On Medical Billing And Compliance To Address California Labs

Lale White, CEO of XIFIN®, Inc., and nationally recognized authority on Medical Billing and Compliance, will conduct a workshop, sponsored by the California Clinical Laboratory Association, focused on the recent changes and trends in Federal reimbursement policy and judicial activities that affect California laboratories.

The workshop will be held on May 16th, from 1:00-5:00 PM, at the Sheraton Gateway Hotel in Los Angeles. Other topics will include changes to Negotiated Rulemaking, Advanced Beneficiary Notice (ABN) guidelines, Medi-cal billing and compliance issues, HIPAA updates and guidance, and Accounts Receivable management. Additionally, a representative from NHIC will participate to discuss changes that affect carriers as well as to answer questions regarding Medicare policies.

"Recent activities by the Institute of Medicine, OIG, Congress and CMS as well as outcomes from judicial actions involving compliance violations have signaled a promising trend in medical reimbursement and compliance enforcement," noted White. "The coordinated activities of these key Federal agencies are demonstrating a more reasoned and practical approach to managing and protecting the Medicare reimbursement program. This ’loosening’ of some of the more onerous requirements will be a welcomed relief to labs, most of whom are already overwhelmed by an enormously complex reimbursement process."

About California Clinical Laboratory Association.
The organization was founded 25 years ago and has been instrumental in the formation and enactment of State and Federal laboratory legislation. Its membership includes 50 of the most influential labs in California. For more information about CCLA and its annual conference, contact Michael Arnold at 916/446-2646.


XIFIN is an innovative software and services company dedicated to optimizing the economics of healthcare. The company's cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making. To learn more, visit, or follow XIFIN on Twitter at!/xifin.


Media Relations

To speak with XIFIN directly, contact Fran DuCharme at 858.436.2939 or complete the form below for assistance.

To speak with our PR firm, contact Julie Sculley at 617.986.5730.